Anti-Human CXC-ELR Therapeutic Antibody (PanELR(PE)N297A)

Recombinant monoclonal antibody to CXC-ELR, PanELR(PE)N297A, is a humanized monoclonal antibody intended for the prophylaxis and treatment of related disease such as ulcerative colitis, Crohn's disease, osteoarthritis, rheumatoid arthritis.
Supplier Creative Biolabs
Product # TAB-100MZ
Pricing Inquiry
Type Humanized antibody
Applications Binding assay
Host Human
Target ELR+ CXC chemokines
Feedback